Literature DB >> 24121505

A disintegrin and metalloprotease (ADAM) 10 and ADAM17 are major sheddases of T cell immunoglobulin and mucin domain 3 (Tim-3).

Katja Möller-Hackbarth1, Christin Dewitz, Olga Schweigert, Ahmad Trad, Christoph Garbers, Stefan Rose-John, Jürgen Scheller.   

Abstract

T cell immunoglobulin and mucin domain 3 (Tim-3) dampens the response of CD4(+) and CD8(+) effector T cells via induction of cell death and/or T cell exhaustion and enhances the ability of macrophages to clear pathogens via binding to galectin 9. Here we provide evidence that human Tim-3 is a target of A disintegrin and metalloprotease (ADAM)-mediated ectodomain shedding resulting in a soluble form of Tim-3. We identified ADAM10 and ADAM17 as major sheddases of Tim-3 as shown by ADAM-specific inhibitors and the ADAM10 pro-domain in HEK293 cells and ADAM10/ADAM17-deficient murine embryonic fibroblasts. PMA-induced shedding of Tim-3 was abrogated by deletion of amino acids Glu(181)-Asp(190) of the stalk region and Tim-3 lacking the intracellular domain was not efficiently cleaved after PMA stimulation. Surprisingly, a single lysine residue within the intracellular domain rescues shedding of Tim-3. Shedding of endogenous Tim-3 was found in primary human CD14(+) monocytes after PMA and ionomycin stimulation. Importantly, the recently described down-regulation of Tim-3 from Toll-like receptor-activated CD14(+) monocytes was caused by ADAM10- and ADAM17-mediated shedding. Inhibition of Tim-3 shedding from lipopolysaccharide-induced monocytes did not influence lipopolysaccharide-induced TNFα and IL-6 but increases IL-12 expression. In summary, we describe Tim-3 as novel target for ADAM-mediated ectodomain shedding and suggest a role of Tim-3 shedding in TLR-mediated immune responses of CD14(+) monocytes.

Entities:  

Keywords:  ADAM ADAMTS; Cell Culture; Cell Surface; Shedding; Signaling

Mesh:

Substances:

Year:  2013        PMID: 24121505      PMCID: PMC3843067          DOI: 10.1074/jbc.M113.488478

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance.

Authors:  Catherine A Sabatos; Sumone Chakravarti; Eugene Cha; Anna Schubart; Alberto Sánchez-Fueyo; Xin Xiao Zheng; Anthony J Coyle; Terry B Strom; Gordon J Freeman; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2003-10-12       Impact factor: 25.606

2.  Leukocyte migration is regulated by L-selectin endoproteolytic release.

Authors:  Guglielmo M Venturi; LiLi Tu; Takafumi Kadono; Adil I Khan; Yoko Fujimoto; Philip Oshel; Cheryl B Bock; Ann S Miller; Ralph M Albrecht; Paul Kubes; Douglas A Steeber; Thomas F Tedder
Journal:  Immunity       Date:  2003-11       Impact factor: 31.745

3.  iRhom2 controls the substrate selectivity of stimulated ADAM17-dependent ectodomain shedding.

Authors:  Thorsten Maretzky; David R McIlwain; Priya Darshinee A Issuree; Xue Li; Jordi Malapeira; Sadaf Amin; Philipp A Lang; Tak W Mak; Carl P Blobel
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-25       Impact factor: 11.205

4.  The cytoplasmic domain of L-selectin participates in regulating L-selectin endoproteolysis.

Authors:  E Matala; S R Alexander; T K Kishimoto; B Walcheck
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

5.  The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion.

Authors:  Christian Hundhausen; Dominika Misztela; Theo A Berkhout; Neil Broadway; Paul Saftig; Karina Reiss; Dieter Hartmann; Falk Fahrenholz; Rolf Postina; Vance Matthews; Karl-Josef Kallen; Stefan Rose-John; Andreas Ludwig
Journal:  Blood       Date:  2003-04-24       Impact factor: 22.113

6.  Shedding of kidney injury molecule-1 by membrane-type 1 matrix metalloproteinase.

Authors:  Luyang Guo; Takahisa Takino; Yoshio Endo; Takahiro Domoto; Hiroshi Sato
Journal:  J Biochem       Date:  2012-07-26       Impact factor: 3.387

Review 7.  TIM-1, a novel allergy and asthma susceptibility gene.

Authors:  Jennifer J McIntire; Dale T Umetsu; Rosemarie H DeKruyff
Journal:  Springer Semin Immunopathol       Date:  2003-10-24

8.  The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts.

Authors:  Dieter Hartmann; Bart de Strooper; Lutgarde Serneels; Katleen Craessaerts; An Herreman; Wim Annaert; Lieve Umans; Torben Lübke; Anna Lena Illert; Kurt von Figura; Paul Saftig
Journal:  Hum Mol Genet       Date:  2002-10-01       Impact factor: 6.150

9.  Minimal interleukin 6 (IL-6) receptor stalk composition for IL-6 receptor shedding and IL-6 classic signaling.

Authors:  Paul Baran; Rebecca Nitz; Joachim Grötzinger; Jürgen Scheller; Christoph Garbers
Journal:  J Biol Chem       Date:  2013-04-05       Impact factor: 5.157

10.  L-selectin shedding does not regulate constitutive T cell trafficking but controls the migration pathways of antigen-activated T lymphocytes.

Authors:  Elena Galkina; Kyriakos Tanousis; Graham Preece; Mauro Tolaini; Dimitris Kioussis; Oliver Florey; Dorian O Haskard; Thomas F Tedder; Ann Ager
Journal:  J Exp Med       Date:  2003-11-03       Impact factor: 14.307

View more
  44 in total

Review 1.  PD-1 immunobiology in systemic lupus erythematosus.

Authors:  Colleen S Curran; Sarthak Gupta; Ignacio Sanz; Elad Sharon
Journal:  J Autoimmun       Date:  2018-11-03       Impact factor: 7.094

2.  Blockade of Tim-3 binding to phosphatidylserine and CEACAM1 is a shared feature of anti-Tim-3 antibodies that have functional efficacy.

Authors:  Catherine A Sabatos-Peyton; James Nevin; Ansgar Brock; John D Venable; Dewar J Tan; Nasim Kassam; Fangmin Xu; John Taraszka; Luke Wesemann; Thomas Pertel; Nandini Acharya; Max Klapholz; Yassaman Etminan; Xiaomo Jiang; Yu-Hwa Huang; Richard S Blumberg; Vijay K Kuchroo; Ana C Anderson
Journal:  Oncoimmunology       Date:  2017-11-09       Impact factor: 8.110

Review 3.  Molecular Pathways: Receptor Ectodomain Shedding in Treatment, Resistance, and Monitoring of Cancer.

Authors:  Miles A Miller; Ryan J Sullivan; Douglas A Lauffenburger
Journal:  Clin Cancer Res       Date:  2016-11-28       Impact factor: 12.531

Review 4.  Targeting novel inhibitory receptors in cancer immunotherapy.

Authors:  Quan-Quan Ding; Joe-Marc Chauvin; Hassane M Zarour
Journal:  Semin Immunol       Date:  2020-12-04       Impact factor: 11.130

5.  Shedding of Endogenous Interleukin-6 Receptor (IL-6R) Is Governed by A Disintegrin and Metalloproteinase (ADAM) Proteases while a Full-length IL-6R Isoform Localizes to Circulating Microvesicles.

Authors:  Neele Schumacher; Dörte Meyer; Andre Mauermann; Jan von der Heyde; Janina Wolf; Jeanette Schwarz; Katharina Knittler; Gillian Murphy; Matthias Michalek; Christoph Garbers; Jörg W Bartsch; Songbo Guo; Beate Schacher; Peter Eickholz; Athena Chalaris; Stefan Rose-John; Björn Rabe
Journal:  J Biol Chem       Date:  2015-09-10       Impact factor: 5.157

Review 6.  Tim-3 and its role in regulating anti-tumor immunity.

Authors:  Madhumita Das; Chen Zhu; Vijay K Kuchroo
Journal:  Immunol Rev       Date:  2017-03       Impact factor: 12.988

7.  Soluble T cell immunoglobulin mucin domain 3 is shed from CD8+ T cells by the sheddase ADAM10, is increased in plasma during untreated HIV infection, and correlates with HIV disease progression.

Authors:  Kiera L Clayton; Matthew B Douglas-Vail; A K M Nur-ur Rahman; Karyn E Medcalf; Irene Y Xie; Glen M Chew; Ravi Tandon; Marion C Lanteri; Philip J Norris; Steven G Deeks; Lishomwa C Ndhlovu; Mario A Ostrowski
Journal:  J Virol       Date:  2015-01-21       Impact factor: 5.103

8.  Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions.

Authors:  Keiko Nagahara; Tomohiro Arikawa; Souichi Oomizu; Keiichi Kontani; Atsuya Nobumoto; Hiroaki Tateno; Kota Watanabe; Toshiro Niki; Shigeki Katoh; Minoru Miyake; Syun-Ichiro Nagahata; Jun Hirabayashi; Vijay K Kuchroo; Akira Yamauchi; Mitsuomi Hirashima
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

Review 9.  Regulation of T cell responses by the receptor molecule Tim-3.

Authors:  Jacob V Gorman; John D Colgan
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

10.  Downregulated Tim-3 expression is responsible for the incidence and development of colorectal cancer.

Authors:  Ping Zhang; Yan Wang; Xue-Rong Liu; Shi-Ru Hong; Jian Yao
Journal:  Oncol Lett       Date:  2018-05-11       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.